SCHEMBL1783266

SCHEMBL1783266

CCCCCCC(O)C(C)C=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.55
CYP2D6 P10635 2/20 0.47
MAPT P10636 2/20 0.47
ADH1B P00325 1/20 0.47
ADH1C P00326 1/20 0.47
ADH1A P07327 1/20 0.47
ADH4 P08319 1/20 0.47
ADH7 P40394 1/20 0.47
GMNN O75496 1/20 0.47
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.47
THPO P40225 1/20 0.47
MTOR P42345 1/20 0.47
BLM P54132 1/20 0.47
KDM4E B2RXH2 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CETP P11597 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1781451 1.00 SPHK1 (0.55) SPHK1CYP2D6MAPTADH1BADH1C
SCHEMBL1786274 0.98 SPHK1 (0.52) SPHK1CYP2D6MAPTADH1BADH1C
SCHEMBL11179784 0.91 TSHR (0.46) SPHK1CYP2D6MAPTADH1BADH1C
SCHEMBL1783784 0.91 TSHR (0.46) SPHK1CYP2D6MAPTADH1BADH1C
SCHEMBL27279991 0.87 ALDH1A1 (0.45) SPHK1CYP2D6ADH1BADH1CADH1A
SCHEMBL1784709 0.83 TRPA1 (0.39) SPHK1MAPTLMNABLMTRPA1
SCHEMBL1782596 0.82
SCHEMBL5499873 0.82
SCHEMBL20820019 0.82 TRPV1 (0.40) SPHK1MAPTTRPA1TRPV1
SCHEMBL7682544 0.81 SPHK1 (0.52) SPHK1CYP2D6MAPTADH1BADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111148739-B Cyclic peptide antibiotics 豪夫迈·罗氏有限公司 2025-06-03 CN disclosed
EP-3681875-A1 CYCLIC PEPTIDE ANTIBIOTICS H. Hoffnabb-La Roche Ag (CH) 2020-07-22 EP disclosed
WO-2019052545-A1 CYCLIC PEPTIDE ANTIBIOTICS F. HOFFMANN-LA ROCHE AG (CH) 2019-03-21 WO disclosed
US-8632792-B2 Cooling sensation agent composition and sensory stimulation agent composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2014-01-21 US disclosed
US-20110117147-A1 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-05-19 US disclosed
WO-2009123355-A2 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110117147-A1 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TRPA1, HRH1, HRH2 SPHK1 1693/4885CYP2D6 2862/4885MAPT 906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.